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Background: A previously discovered mutant of Saccharomyces cerevisiae alcohol dehydrogenase 1 (Adh1p) was
shown to enable a unique NADH-dependent reduction of 5-hydroxymethylfurfural (HMF), a well-known inhibitor of
yeast fermentation. In the present study, site-directed mutagenesis of both native and mutated ADH1 genes was
performed in order to identify the key amino acids involved in this substrate shift, resulting in Adh1p-variants with
different substrate specificities.
Results: In vitro activities of the Adh1p-variants using two furaldehydes, HMF and furfural, revealed that HMF
reduction ability could be acquired after a single amino acid substitution (Y295C). The highest activity, however,
was reached with the double mutation S110P Y295C. Kinetic characterization with both aldehydes and the in vivo
primary substrate acetaldehyde also enabled to correlate the alterations in substrate affinity with the different amino
acid substitutions.
Conclusions: We demonstrated the key role of Y295C mutation in HMF reduction by Adh1p. We generated and
kinetically characterized a group of protein variants using two furaldehyde compounds of industrial relevance. Also,
we showed that there is a threshold after which higher in vitro HMF reduction activities do not correlate any more
with faster in vivo rates of HMF conversion, indicating other cell limitations in the conversion of HMF.
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Cost-efficient bioethanol production from lignocellulosic
hydrolysates is in demand nowadays as a renewable
liquid fuel [1,2]. However, the efficient fermentation of
the complex raw material confronts several challenges,
one of which being growth-inhibiting substances released
during pretreatment and hydrolysis of lignocellulose [3].
During pretreatment of the biomass, two furaldehydes,
HMF (5-hydroxymethylfurfural) and 2-furfural, are pro-
duced as the result of dehydration of hexose and pentose
sugars, respectively [4,5]. Both HMF and furfural inhibit
growth of S. cerevisiae and show synergistic effects [6].
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unless otherwise stated.yield and productivity [7] and the inhibition of several
key enzymes by furfural [8], among which is alcohol
dehydrogenase (EC 1.1.1.1). Native S. cerevisiae cells
are able to reduce HMF and furfural in vivo to the less
inhibitory alcohols [6,9], however at a low and strain-
dependent rate.
We previously isolated and characterized a mutated gene
variant of S. cerevisiae ADH1 [10] from strain TMB3000,
found at a spent sulfite liquor fermentation plant [11].
Whereas native Adh1p (natAdh1p) primarily catalyzes
the reduction of acetaldehyde to ethanol using NADH as a
co-factor [12], and was shown to reduce the smaller mol-
ecule formaldehyde [13], the mutated variant (mutAdh1p)
also reduced the larger compound HMF using NADH as
a co-factor [10]. All other known S. cerevisiae HMF reduc-
tases, including Adh6p, had been described as being
NADPH dependent [14]. The nucleotide sequence ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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While three of the reported mutations were present in
previously published sequences [15] the other three
mutations were novel and shown to reside in the
vicinity of the substrate-binding pocket [10].
In the present study, the effect of individual mutations
was evaluated through site-directed mutagenesis of
both natAdh1p (Figure 1) and mutAdh1p. The different
variants displayed a wide range of reduction rates with
several substrates and the comparison revealed the
effects of both novel and previously reported mutations.
Five variants were kinetically characterized, revealing dis-
tinct differences between affinity constants and maximal
velocity values for both furaldehyde and acetaldehyde sub-
strates. The variant displaying the highest in vitro activity
with HMF was evaluated for in vivo HMF reduction.
Results
Generation and in vitro activity of Adh1p-variants
In the present study we generated a group of Adh1p-
variants based on six mutations previously identified in
the industrial S. cerevisiae strain TMB3000. Through
enzymatic assays using the furaldehyde compounds
HMF and furfural, alterations in the reduction capacity
of the variants were analyzed in relation to the amino
acid changes.
The first three variants were created by mutagenesis of
the originally isolated mutated ADH1 gene from TMB3000Figure 1 Active site of wild-type Adh1p from S. cerevisiae.
Residues mutated during this work (Val59, Ser110, Leu117, Gln148,
Ile152 and Tyr295) are presented as stick models (orange) together
with NAD(H) analogue nicotinamide-8-iodo-adenine-dinucleotide
and substrate analogue trifluoroethanol (white). Structural and
active-site zink are shown as spheres (green). The image was created
in PyMol (www.pymol.org) from the atomic coordinates in 2HCY.[10] encoding a protein designated here as mutAdh1p
(Table 1). The three novel mutations found within the
protein (S110P, L117S, Y295C) were changed indivi-
dually back to their native state. The resulting protein
variants were designated, respectively, mutAdh1p-rev110,
mutAdh1p-rev117 and mutAdh1p-rev295 (Table 1).
NADH-dependent reduction of HMF and furfural were
compared using the lysate of the strains carrying the three
new Adh1p-variants, the strain carrying mutAdh1p and a
control strain (reference plasmid) (Figure 2). mutAdh1p
exhibited an HMF activity of 0.80 U/mg total protein,
while cell extract of the reference strain showed no activity
with HMF. The three mutants, however, showed a signifi-
cant change of activity with altering a single amino acid.
Reversion at position 110 (mutAdh1p-rev110) led to over
80% reduction in HMF activity (0.13 U/mg total protein),
while reversion at position 295 (mutAdh1p-rev295) abol-
ished HMF activity, indicating a potential role in the
acquired HMF reduction ability. In contrast, reversion
at position 117 (mutAdh1p-rev117) led to a 3-fold
increase (2.39 U/mg total protein) in specific activity
against HMF (Figure 2).
With furfural, mutAdh1p showed an activity of 0.78
U/mg total protein while the control strain showed a de-
crease of over 40% to 0.42 U/mg total protein (Figure 2).
Each reversion led to an increase in furfural reduction:
more than 20% (0.99 U/mg total protein and 0.98 U/mg
total protein) for mutAdh1p-rev110 and mutAdh1-
rev295, respectively and almost a 3-fold increase in
activity for mutAdh1p-rev117 (2.20 U/mg total protein).
In view of these results, natAdh1p was mutated at
positions 110 and 295. Native ADH1 gene was amplified
from genomic DNA of CEN.PK 113-5D and overex-
pressed in the same strain (designated CEN.PK 113-5D
[natAdh1p]). Site-directed mutagenesis of native ADH1
resulted in two more protein variants designated
natAdh1p-m110 (S110P) and natAdh1p-m295 (Y295C)
(Table 1). NADH-dependent HMF and furfural activitiesTable 1 Amino acid changes among the different
Adh1p-variants
Variant Position
59 110 117 148 152 295
natAdh1p V S L Q I Y
mutAdh1p T P S E V C
mutAdh1p-rev110 T S S E V C
mutAdh1p-rev117 T P L E V C
mutAdh1p-rev295 T P S E V Y
natAdh1p-m110 V P L Q I Y
natAdh1p-m295 V S L Q I C
natAdh1p-m110, 295 V P L Q I C
mutAdh1p-rev110,117 T S L E V C
Figure 2 Specific activity against HMF (filled bars) and furfural (empty bars) of strains carrying different variants of Adh1p (see Table 1 for
description). Absence of bar means not activity could be detected. One unit (U) corresponds to 1 μmol of NADH oxidized per min, at 30°C and pH 6.7.
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(Figure 2). As expected from previous results, natAdh1p
showed no activity against HMF. natAdh1p-m110 did
not show activity with HMF either. natAdh1p-m295, on
the contrary, showed an activity of 1.20 U/mg total pro-
tein, which represents a 50% increase compared with
mutAdh1p. With furfural, all variants displayed a consid-
erable increase in activity as compared with mutAdh1p:
over 60% for natAdh1p (1.27 U/mg total protein) as
well as 3.6-fold (2.80 U/mg total protein) and 7.7-fold
(6.04 U/mg total protein) increase for natAdh1p-m110
and natAdh1p-m295, respectively (Figure 2).
In order to further understand how different amino
acids influenced the substrate specificity of Adh1p, two
more mutants were created. NatAdh1p was mutated at
positions S110P and Y295C, and named natAdh1-m110,
295 (Table 1). In mutAdh1p two changes, P110S and
S117L were performed, resulting in variant mutAdh1p-
rev110, 117. Reversion at positions 110 and 117 gave
slightly higher HMF activity (0.96 U/mg total protein)
than mutAdh1p but the highest HMF activity of all var-
iants was obtained for natAdh1p-m110, 295 (5.54 U/mg
total protein) (Figure 2). Furfural activity was high for
both new variants, with 4.85 U/mg total protein for
mutAdh1p-rev110, 117 and 2.04 U/mg total protein for
natAdh1-m110, 295 (Figure 2).
The possible effect of ADH1 gene dosage on Adh1p
activities was determined using a relative quantification
assessment of plasmid copy number between strainscarrying mutAdh1p and natAdh1p-m110, 295. qPCR
data showed indistinguishable quantification values
between both strains (data not shown). Therefore, since
no difference in plasmid copy number was observed
between these strains at the moment of harvesting, the
differences in activities previously described with both
furaldehydes are rather a direct result of the mutations
in the ADH1 gene. In addition, and considering that all
strains were harvested at comparable physiological state
and cell density, it is very likely that the amino acid
substitutions, rather that differences in gene dosage, are
also responsible for the variations in activities observed
between the other strains.
Kinetics of Adh1p-variants
Variants natAdh1p, mutAdh1p and its derivative that
was reverted at position 117 (mutAdh1p-rev117), as well
as natAdh1p-m110, 295 and mutAdh1p-rev110, 117 were
further kinetically characterized. Kinetic parameters were
determined by introducing the corresponding genes in
strain BY4741 that lacked ADH1 gene (Table 2) and meas-
uring NADH-dependent HMF, furfural and acetaldehyde
reduction in the cell extracts. The parameters Vmax, Km
and Ki were determined from the model described in the
section Materials and methods; where the parameter
Ki represents the inhibition factor, with higher values
implying lower inhibition. [S]Vmax represents the sub-
strate concentration at which the experimental Vmax
(observed Vmax) was measured. The RSQ value stands
Table 2 Strains used in the study
S. cerevisiae strains Relevant genotype Reference
CEN.PK 113-5D Mata ura3 [16]
Control (reference plasmid) CEN.PK 113-5D, YEplacHXT [10]
CEN.PK 113-5D [natAdh1p] CEN.PK 113-5D, YEplacHXT-natADH1 This study
CEN.PK 113-5D [mutAdh1p] CEN.PK 113-5D, YEplacHXT-mutADH1 [10]
CEN.PK 113-5D [mutAdh1p-rev110] CEN.PK 113-5D, YEplacHXT-mutADH1-rev110 This study
CEN.PK 113-5D [mutAdh1p-rev117] CEN.PK 113-5D, YEplacHXT-mutADH1-rev117 This study
CEN.PK 113-5D [mutAdh1p-rev295] CEN.PK 113-5D, YEplacHXT-mutADH1-rev295 This study
CEN.PK 113-5D [natAdh1p-m110] CEN.PK 113-5D, YEplacHXT-natADH1-m110 This study
CEN.PK 113-5D [natAdh1p-m295] CEN.PK 113-5D, YEplacHXT-natADH1-m295 This study
CEN.PK 113-5D [natAdh1p-m110, 295] CEN.PK 113-5D, YEplacHXT-natADH1-m110, 295 This study
CEN.PK 113-5D [mutAdh1p-rev110, 117] CEN.PK 113-5D, YEplacHXT-mutADH1-rev110, 117 This study
BY4741 Mat-a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0,
deleted ORF YOL086C (adh1)
EUROSCARF collection, Heidelberg, Germany
BY4741 [natAdh1p] BY4741, YEplacHXT-natADH1 This study
BY4741 [mutAdh1p] BY4741, YEplacHXT-mutADH1 This study
BY4741 [mutAdh1p-rev117] BY4741, YEplacHXT-mutADH1-rev117 This study
BY4741 [natAdh1p-m110,295] BY4741, YEplacHXT-natADH1-m110, 295 This study
BY4741 [mutAdh1p-rev110,117] BY4741, YEplacHXT-mutADH1-rev110, 117 This study
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variability between the data set and the statistical
model, with value 1 specifying a perfect correlation.
The background activity in cell extract of the ΔAdh1
strain was low for all the substrates (0.02 U/mg total
protein for acetaldehyde and furfural; 0.01 U/mg total
protein for HMF).
The cell cultures of the different BY4741 strains used
for kinetic characterization were harvested at the same
physiological state and comparable cell densities, and
the analysis focused on the differences in activities (with
HMF and furfural) within each variant in relation to the
natural substrate acetaldehyde.
The results from the kinetic characterization showed
that the various mutations altered the activity of the
variants with the substrates to different extent (Table 3).
For natAdh1p, HMF activity was not detected, while the
activity with furfural was about 14% of that measured
with acetaldehyde. The variant mutAdh1p, on the other
hand, showed activity with HMF, corresponding to about
66% of the activity obtained with acetaldehyde as sub-
strate. For this variant, the activity with furfural was
lower than that with HMF, since it was only around 34%Table 3 Ratio of activities for the Adh1p-variants with substra
with the natural substrate acetaldehyde during the kinetic ch
Ratio of activities natAdh1p mutAdh1p mutAdh1p
Vmax HMF
Vmax acetaldehyde 0.00 0.66 0.27
Vmax furfural
Vmax acetaldehyde 0.14 0.34 0.51of that obtained with acetaldehyde (Table 3). The other
variant studied, mutAdh1p-rev117 showed a different
preference in substrate. This variant displayed, with
HMF and furfural respectively, around 27% and 50% of
the activity obtained with acetaldehyde (Table 3). The
variant natAdh1p-m110, 295 showed similar ratios on
activities as the mutAdh1p, that is, its activity with
HMF was close to 70% of the activity measured with
acetaldehyde, and with furfural only around 34% of that
obtained with the reference substrate. Finally, mutAdh1p-
rev110, 117 showed a low activity with HMF and furfural
(11% and 24% of the activity obtained with acetaldehyde
respectively) (Table 3).
The kinetics also highlighted differences in affinity
constant (Km) and substrate inhibition constants (Ki)
between the substrates (Table 4). For natAdh1p, the
affinity constant Km was much lower for acetaldehyde
than for furfural (0.22 mM vs. 18.80 mM). However, this
variant did not show inhibition by furfural at concentra-
tions up to 30 mM, while inhibition by acetaldehyde
was observed around 1 mM (Table 4). The Km values
obtained for mutAdh1p were 1.69 mM (acetaldehyde),
4.30 mM (HMF) and 0.04 mM (furfural) (Table 4).tes HMF and furfural in relation to the activity obtained
aracterization
-rev117 natAdh1p-m110, 295 mutAdh1p-rev110, 117
0.67 0.11
0.34 0.24
Table 4 Kinetic parameters of the Adh1p-variants with acetaldehyde, HMF and furfural as substrates
Variant Substrates Vmax (mU/mg) Km (mM) Ki (mM) [S]Vmax, (obsVmax)* RSQ
natAdh1p Acetaldehyde 45070 0.22 12.53 1 (35300) 0.987
HMF Not detected
Furfural 6530 18.8 1363 30 (4345) 0.970
mutAdh1p Acetaldehyde 4736 1.69 49 10 (3700) 0.968
HMF 3120 4.30 9.82 5–10 (1320) 0.984
Furfural 1625 0.04 1.07 0.25 (1230) 0.974
mutAdh1p-rev117 Acetaldehyde 23060 1.74 96 10–25 (17600) 0.979
HMF 6320** 4.28 n.d 10 (4900) 0.975
Furfural 11700 0.33 4.40 1 (7600) 0.992
natAdh1p-m110, 295 Acetaldehyde 16509 0.83 46 5 (14300) 0.970
HMF 11090 9.45 20.80 10–20 (4560) 0.999
Furfural 5657 0.13 1.32 0.25–0.5 (3480) 0.984
mutAdh1p-rev110,117 Acetaldehyde 32455 3.03 56 10 (22000) 0.974
HMF 3640 13.10 27.30 20 (1550) 0.980
Furfural 7792 0.34 6.66 1 (5320) 0.986
*[S]Vmax – substrate concentration (mM) at observed Vmax (obsVmax, mU/mg), **Vmax and Km values derived from a model without substrate inhibition factor, see
text for details.
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around concentration of 10 mM of these substrates, while
with furfural inhibition was observed at lower concen-
trations (around 0.25 mM). For the variant mutAdh1p-
rev117, the Km values obtained were 1.74 mM, 4.28 mM
and 0.33 mM for acetaldehyde, HMF and furfural respect-
ively (Table 4). Inhibition by acetaldehyde was observed
above 25 mM, for HMF around 10 mM while with
furfural above 1 mM. For natAdh1p-m110, 295, the Km
values were lower than one for acetaldehyde (0.83 mM)
and furfural (0.13 mM), and with HMF the Km calculated
was 9.35 mM. This variant was less inhibited by HMF
(above 20 mM) than by acetaldehyde (inhibition observed
above 5 mM). With furfural, however, inhibition was
observed at concentrations above 0.50 mM. Finally, the
Km values obtained for mutAdh1p-rev110, 117 were
3.03 mM, 13.10 mM and 0.34 mM for acetaldehyde,
HMF and furfural respectively. Inhibition by acetaldehyde
was observed at concentrations above 10 mM, while
inhibition by HMF and furfural were evident above
20 mM and 1 mM respectively (Table 4).In vivo HMF conversion
Anaerobic batch fermentations in the presence of 2 g/L
HMF were carried out to compare the in vivo HMF
reduction capacity of strain CEN.PK 113 5D [mutAdh1p]
and the strain showing the highest in vitro HMF/acetalde-
hyde reduction ratio CEN.PK 113 5D [natAdh1p-mut110,
295]. A control strain carrying a reference plasmid was also
included. The concentration of HMF was chosen according
to levels previously reported in spruce hydrolysate [17].The in vivo HMF uptake rate of the control strain
(0.14 g/g cell. h) was the same as the one previously
reported for the S. cerevisiae strain CBS 8066 under
similar conditions [6]. For the strains carrying the two
mutants, the in vivo values were equivalent, and more
than three times higher than for the control strain
(Table 5). In agreement with this result, both strains
overexpressing the mutated ADH1 genes performed very
similarly during the fermentations (Figure 3, Table 5) and
displayed much higher glucose consumption rate than the
control strain (Table 5). Strains overexpressing ADH1 also
showed slightly lower concentrations of glycerol when
compared to the control. But final ethanol yields and
product distribution was similar for the rest of metabolites
between the three strains (Table 6). When the values of
in vitro specific activity were compared with the in vivo
rates of HMF uptake, it was found that the capacity for
HMF reduction in vitro was around five times and thirty
seven times higher (for CEN.PK 113-5D [mutAdh1p] and
CEN.PK 113-5D [natAdh1p-m110, 295] respectively) than
during the fermentations (Table 5).
Discussion
The study aimed at unraveling the importance of the
different mutations identified in a previously described
Adh1p mutant displaying an unusual NADH-dependent
HMF reductase activity [10]. Here we demonstrated the
key role of Y295C mutation in HMF reduction, but also
the overall negative impact of L117S mutation on fural-
dehyde reduction. We previously hypothesized that the
replacement of tyrosine with cysteine at position 295
resulted in the widening of the substrate binding pocket,
Table 5 In vitro and in vivo conversion rate of HMF and specific growth, glucose consumption and ethanol production
rates in anaerobic batch fermentation in defined mineral medium supplemented with 2 g/l HMF
Strain In vitro HMF reductiona
(g/g cells. h)






Control ndb 0.14 ± 0.00 0.07 ± 0.00 1.54 ± 0.09 0.58 ± 0.06
CEN.PK 113-5D [mutAdh1p] 2.57 ± 0.32 0.47 ± 0.03 0.13 ± 0.01 2.96 ± 0.63 1.19 ± 0.09
CEN.PK 113-5D [natAdh1p-m110, 295] 17.81 ± 2.68 0.48 ± 0.00 0.13 ± 0.01 3.08 ± 0.70 1.17 ± 0.16
aThe in vitro activities for these strains were recalculated as gHMF converted per gram of cells per hour. This allowed the comparison between the conversion
rates during the fermentation and the in vitro measurements. bNot detected.
Rates were calculated during exponential growth. Presented values are the mean of two independent biological replicates.
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molecule [10]. However, natAdh1p can reduce the bulky
furfural substrate, as displayed here and elsewhere [18].
We therefore speculate that acquisition of HMF and
increase in furfural reduction capability by Y295C muta-
tion relies not only on an enlarged binding pocket, but
also in the differences in properties, such as the polarity of
the side chain, between tyrosine and cysteine. We also
demonstrated that the acquired mutation at position 117,
whose neighbor amino acids belong to the substrate-
binding pocket [19], was disadvantageous for furaldehyde
reduction as the reduction capacity to both furaldehydes
was increased when the polar amino acid serine was
reverted back to the original hydrophobic amino acidFigure 3 Comparison of glucose/HMF consumption and acetate/glyce
the presence of HMF for the control strain (A) and strains CEN.PK 113
(C). Legend: ●-glucose, ○-glycerol, X-acetate, ▲-ethanol, Δ-HMF, □-biomas
figure shows the data of one representative profile for each strain. The stanleucine. Finally, mutation S110P could not by itself
generate activity against HMF as demonstrated with
natAdh1p-m110, but it proved to be important for
HMF reduction since reversion of the mutation in
mutAdh1p-rev110 led to significantly lower reduction
activity. Also combining S110P and Y295C mutations
(natAdh1p-m110, 295) led to a 4.6-fold increase in specific
activity towards HMF. In contrast, this combination led to
a 3-fold decrease in furfural reduction activity whereas
both individual mutations gave higher furfural reduction
levels than natAdh1p. Therefore the impact of mutation
S110P appears to be dependent on the substrate and the
presence of other surrounding mutations. It should be
emphasized however, that is not possible to explain therol/ethanol/biomass formation during anaerobic cultivations in
5D [mutAdh1p] (B) and CEN.PK 113 5D [natAdh1p-mut110, 295]
s. The experiment was performed in biological duplicates and the
dard deviation between replicates was less than 15%.
Table 6 Ethanol, biomass, glycerol and acetate yields in anaerobic batch fermentation in defined mineral medium with
40 g/l glucose and supplemented with 2 g/l HMF
Strain Yethanol Ybiomass Yglycerol Yacetate
Control 0.38 ± 0.06 0.04 ± 0.01 0.10 ± 0.01 0.03 ± 0.00
CEN.PK 113-5D [Adh1 (59, 110, 117, 148, 152, 295)] 0.41 ± 0.06 0.05 ± 0.01 0.09 ± 0.02 0.03 ± 0.01
CEN.PK 113-5D [Adh1 (110, 295)] 0.38 ± 0.04 0.05 ± 0.01 0.08 ± 0.01 0.03 ± 0.00
Yields are expressed as g of product per g of glucose. Presented values are the mean of two independent biological replicates ± standard deviation.
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from the changes in the primary structure of the proteins.
Although some changes in the protein properties can be
inferred by the differences in the properties of the amino
acids that have been altered (e.g. polarity and charge), the
final effect that such changes can have in the biological
function of the enzyme requires a deeper analysis. The
prediction of possible relevant changes in the tertiary
structures of the protein (for example in the active site
or co-factor binding site) based on the mutations here
described goes beyond the aim of this study.
Kinetic measurements also revealed important additional
features for the mutations. First it enabled the analysis of
the influence of the three mutations previously reported in
natAdh1p at positions 59, 148 and 152 [15]. For example,
the activity of mutAdh1p-rev117 with HMF was only
27% of that with acetaldehyde, while for natAdh1p-
m110, 295 the activity with HMF was close to 70% of
the activity obtained with acetaldehyde. Considering that
these variants have the same amino acids positions at 110,
117 and 295 but differ by amino acids at positions 59, 148
and 152, the relevance of these three mutations on the
enzymes properties was proven. The kinetic character-
ization also gave insights on how the alterations in
particular amino acids affected the inhibition properties
of the enzymes by the three analyzed substrates. For
instance, although mutAdh1p-rev110, 117showed the
relatively highest activity with furfural, it was inhibited
by this substrate at very low concentrations (~1 mM)
suggesting that the use of this variant for detoxification
of high-furfural containing hydrolysates (up to 20 mM;
[3]) would probably be limited.
The use of yeast strains with enhanced levels of fural-
dehyde reductases has proven to be a successful strategy
for minimizing the negative effects of different compounds
present in lignocellulosic hydrolysates [17,20]. In general,
higher in vitro conversion rates of HMF (and furfural) have
been correlated with improved fermentation performances
in the presence of these inhibitors [6,21]. In our study, the
in vivo HMF specific uptake rate could indeed be increased
from 0.14 g/g cell. h (control strain) to a maximum
value of 0.48 g/g cell.h when overexpressing ADH1-
variants. However, the laboratory strain expressing the
most promising mutant, natAdh1p-m110, 295, did not
show better in vivo performances than its counterpartexpressing the original mutated gene during anaerobic
fermentation on glucose in the presence of 2 g/l HMF,
despite higher measured Vmax for natAdh1pn110,
295. Nilsson et al. [22] obtained similar results during
fed-batch fermentation with HMF. In that case, the
in vivo conversion rate equaled the total reduction
capacity of the cells for a poorly performing strain
whereas the total in vitro enzyme activity was much
higher than the specific in vivo uptake rate of HMF for
the industrial isolate TMB3000 that carries ADH1 original
mutant. Taken together, these results suggest that there
may be a limit above which the specific uptake rate of
HMF cannot be improved by further increasing the
reduction capacity of the cells. The adaptation response
of S. cerevisiae to HMF has been shown to involve dif-
ferent components including inhibitor detoxification,
alteration of pathways for ATP production and co-factor
regeneration, transportation of toxic metabolites and
degradation of damaged proteins [23]. Transcriptome
studies have shown that multidrug-transporters were
up-regulated in the presence of furaldehydes [24], but
there is not information available on how fast the reduced
forms of the furaldehydes are transported outside the cells
and on the level of inhibition caused by these compounds.
The availability of cofactors inside the cells may also
explain the limitation observed in the in vivo HMF con-
version. In contrast to in vitro enzymatic assays, where
the co-factors are added in excess and the reaction
under study is “isolated” from other cells reactions, the
intracellular concentrations of co-factors are carefully
balanced and regulated by the many other reactions in
which both pairs, NADH/NAD+ and NADPH/NADP+
participate [25]. It has recently been shown that when
yeast cells were grown in chemostat in the presence of
HMF and furfural, the levels of both NAD(P)H and
NAD(P)+ were perturbed and a reduction in biosynthetic
capacity was observed, due to the drainage of NADPH
in the presence of the aldehydes [26]. In another study,
the NADH-specific conversion of HMF led to reduced
glycerol and increase biomass formation in a continuous
cultivation with defined mineral medium [17], which
could indicate a competition for NADH usage. So the
co-factor used during furaldehyde reduction may impact
the product distribution in favor of either NADH or
NADPH consuming routes. And under the stress imposed
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variants may be able to use the available NADH for reduc-
tion purposes only as long as the regeneration of this co-
factor can take place and at a fast enough rate.
Conclusions
The results presented here unravel the impact of single
mutations on the substrate specificity of a key S. cerevisiae
metabolic enzyme and identify tyrosine 295 as the key
amino acid to mutate for getting HMF reduction capacity.
From a more applied perspective, the results reaffirm
that high reduction capacity is a relevant trait for fural-
dehyde bio-detoxification. Combination of this feature
with further improvements in other type of mechanisms
involved in inhibitor tolerance, will lead to the develop-
ment of more robust strains for 2nd generation chemical
production.
Materials and methods
Strains and cultivation conditions
Saccharomyces cerevisiae strains are summarized in
Table 2. The strains were stored in 15% glycerol at −80°C.
Cells from freshly streaked SD-ura plates [27] were used
for pre-culture inoculation. Escherichia coli strain DH5α
(Life Technologies, Rockville, MD, USA) that was used for
cloning purposes was grown in Luria-Bertani medium
[27] supplemented or not with ampicillin (50 μg/mL) and
also stored in 15% glycerol at −80°C.
Molecular biology methods
Competent E. coli cells were prepared using the Inoue
method [28]. Transformants were selected on LB plates
[27] containing 50 μg/mL ampicillin (ICN Biomedicals,
Aurora, OH, USA). The lithium acetate method was used
for transformation of S. cerevisiae [29]. Transformants
were selected on SD-ura [27] plates. Restriction enzymes,
T4-nucleotide ligase and shrimp alkaline phosphatase
were purchased from Fermentas (Vilnius, Lithuania)
whereas Pwo polymerase was purchased from Roche
Diagnostics AB (Bromma, Sweden). All enzymes were
used according to the manufacturers’ recommendations.
PCR fragments were purified using the E.Z.N.A cycle-pure
kit (Omega Bio-Tek, Doraville, GA, USA). Plasmids were
prepared using the QIAprep Spin Miniprep Kit (Qiagen,
Hilden, Germany). DNA sequencing was performed using
the Abi-Prism BigDye cycle sequencing kit (Applied Bio-
systems, Weiterstadt, Germany). Plasmid YEplacHXT [17]
was used for cloning steps, its constitutive truncated HXT
promoter [30] governing the overexpression of ORFs.
Plasmids used in this study are described in Table 7.
Native ADH1 cloning
Extraction of genomic DNA from strain CEN.PK 113-5D
was conducted using the Y-PER kit (Pierce, Rockford, IL,USA) according to the manufacturer’s recommendations.
Amplification of native ADH1 from CEN.PK 113-5D gen-
omic DNA was performed as previously described [10]
using primers Sense BamHI and Antisense BglII (Table 8).
The single resulting amplicon was cleaved with BamHI
and BglII and used for ligation with previously double-
cleaved and de-phosphorylated YEplacHXT plasmid.
Site-directed mutagenesis
For site directed mutagenesis, a two-step PCR was used
for the generation of an ORF containing the correct
nucleotide changes. Plasmids YEplacHXT-mutADH1 and
YEplacHXT-natADH1 (Table 7) were used as PCR
templates for reverse mutagenesis of mutated ADH1
from TMB3000 and mutagenesis of native ADH1 from
CEN.PK 113-5D, respectively. Table 8 lists the primers
used for PCR mediated mutagenesis. The first round
combined Sense BamHI and corresponding antisense
primer and, a separate reaction with primers Antisense
BglII and corresponding sense primer. The two resulting
amplicons were used in the second reaction as template
with primers Sense BamHI and Antisense BglII. The
resulting single amplicon was digested and ligated as
described previously. All PCR reactions had an annealing
step at 55°C, 1 minute elongation time and 30 cycles. All
Adh1p-variants are designated by the protein of origin
(natAdh1p or mutAdh1p) followed by an indication of the
position where the mutation or reversion was introduced.
Therefore, natAdh1p-m295 refers to natAdh1p after
mutagenesis at position 295; and mutAdh1p-rev117
refers to the mutAdh1p [10] after reverse mutagenesis of
position 117 (Table 1). Strain names of either CEN.PK
113-5D or BY4741 hosts include their Adh1p designation
in parentheses (Table 2).
Protein extraction
The cultures were grown until late exponential phase, and
harvest at similar cellular densities. Cells were washed twice
with double distilled water before being re-suspended in
Y-PER detergent (Pierce), 1.7 ml/g cells. After gentle shak-
ing at room temperature for 50 minutes the suspension
was centrifuged for 20 minutes at 15,000 g. The lysate was
collected for spectrophotometric assays. Protein concen-
tration was determined with the Coomassie protein assay
reagent (Pierce) in the Bradford assay according to the
manufacturer’s recommendations.
Alcohol dehydrogenase activity and kinetics
NADH-dependent aldehyde reduction was determined
according to [32], using 200 μM NADH. All measurements
were performed in biological duplicates and technical
triplicates at 30°C in a U-2000 spectrophotometer (Hitachi,
Tokyo, Japan). Reduction kinetics was determined
for acetaldehyde (range 500 μM–100 mM), furfural
Table 7 Plasmids used in the study
Plasmid Construction background Reference
YEplacHXT (reference plasmid) YEplac195, HXT7p-PGKt URA3 [31]
YEplacHXT-natADH1 YEplacHXT, native ADH1 This study
YEplacHXT-mutADH1 YEplacHXT, mutated ADH1 [10]
YEplacHXT-mutADH1-rev110 YEplacHXT, mutated ADH1, P110S This study
YEplacHXT-mutADH1-rev117 YEplacHXT, mutated ADH1, S117L This study
YEplacHXT-mutADH1-rev295 YEplacHXT, mutated ADH1, C295Y This study
YEplacHXT-natADH1-m110 YEplacHXT, native ADH1, S110P This study
YEplacHXT-natADH1-m295 YEplacHXT, native ADH1, Y295C This study
YEplacHXT-natADH1-m110,295 YEplacHXT, native ADH1, Y295C, S110P This study
YEplacHXT-mutADH1-rev110, 117 YEplacHXT, mutated ADH1, P110S, S117L This study
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natAdh1p, furfural was used up to 40 mM. One unit
(U) corresponds to 1 μmol of NADH oxidized per
min, at 30°C and pH 6.7. All the enzymatic activities
are reported as unit of activity per milligram of total
protein (U/mg total protein).
Kinetic modeling
Modeling was performed according to the Michaelis-
Menten equation with the addition of a substrate inhib-
ition constant:
V ¼ Vmax : S½ 
Kmþ S½  þ S½ 2Ki
where V is velocity; Vmax is maximal velocity; [S] is sub-
strate concentration; Km is affinity constant; and Ki is
substrate inhibition constant. Parameter value estimation
was according to the least square method, using the
solver function in Microsoft® Excel 2002. HMF activity
parameters for strain BY4741 [mutAdh1p-rev117] were
estimated without the substrate inhibition constant dueTable 8 Primers used for site-directed mutagenesis












Antisense BglII CTTTAGATCTTTATTTAGAAGTGTCAACAACGto a clear discrepancy of the substrate inhibition model
with actual data.
Batch fermentation with HMF
Inoculum cultures were grown overnight at 30°C in 1 L
cotton plugged shake-flasks with 100 mL of double con-
centrated defined mineral medium [33] supplemented
with 40 g/L glucose and 50 mM potassium hydrogen
phthalate buffer (adjusted to pH 5.5 with potassium
hydroxide) The same medium was used in batch experi-
ments, without the buffer and, when indicated, with 2 g/L
HMF. The starting OD620 was 0.2. Fermentation was
carried out in 800 ml medium at 30°C in 1.4 L Multifors
bioreactor (Infors, Switzerland). Anaerobic conditions were
maintained by continuously sparging 0.2 L/min N2 gas.
The pH 5.5 was kept constant by addition of 3 M KOH.
The stirring rate was 200 rpm.
Analysis of fermentation data
Samples for metabolites and OD were regularly withdrawn
from the reactor. For biomass determination, 5 mL culture
was washed with distilled water and dried on Gelman
filters (ø 47 mm Supor-450, 0.45 μm) in a microwave oven
(350 W) for 8 minutes. The biomass concentration was
correlated with OD620 by dry weight measurements.
Glucose, ethanol, HMF, glycerol and acetic acid were
analysed by high performance liquid chromatography
(HPLC; Waters Corporation, MA, USA) on an Aminex
HPX-87H column (Bio-Rad, CA, USA) at 65°C. The
mobile phase was 5 mM sulphuric acid with a flow of
0.6 mL/min. All compounds were detected with a refract-
ive index detector (Shimadzu, Tokyo, Japan).
The specific HMF uptake rates were calculated accord-
ing to the formula:
qhmf ¼ μ : m
where:
μ =maximum specific growth rate (1/h)
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(gHMF/L) in the Yaxis vs. cdw (g cell/L) in the X-axis at
each time point of the exponential phase.
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